OKYO — OKYO Pharma Share Price
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall Cap
- $98.44m
- $97.62m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | -397.13% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Mar | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
OKYO Pharma Limited is a United Kingdom-based clinical stage biopharmaceutical company developing therapies for the treatment of dry eye disease (DED) and neuropathic corneal pain (NCP). The Company is focused on the discovery and development of novel molecules to treat inflammatory DED and ocular pain. Its research program is focused on a novel G Protein-Coupled Receptor (GPCR). The Company is developing OK-101, its lead preclinical product candidate, for the treatment of DED. OK-101 is focused on keratoconjunctivitis sicca, commonly referred to as DED, which is a multifactorial disease caused by an underlying inflammation resulting in the lack of lubrication and moisture in the surface of the eye. The Company also plans to evaluate its potential in benefiting patients with ocular neuropathic pain, uveitis and allergic conjunctivitis. It is also evaluating OK-201, a bovine adrenal medulla (BAM), lipidated-peptide preclinical analogue candidate that is in the developmental stage.
Directors
- Last Annual
- March 31st, 2022
- Last Interim
- September 30th, 2022
- Incorporated
- July 3rd, 2018
- Public Since
- July 17th, 2018
- No. of Employees
- 7
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 59,300,732
- Address
- Floor 4, 14/15 Conduit St, LONDON, W1S 2XJ
- Web
- https://okyopharma.com/
- Phone
- +44 2074952379
- Auditors
- MAZARS LLP
Upcoming Events for OKYO
Similar to OKYO
60 Degrees Pharmaceuticals
NASDAQ Capital Market
Aadi Bioscience
NASDAQ Capital Market
Acasti Pharma
NASDAQ Capital Market
Agriforce Growing Systems
NASDAQ Capital Market
Aptorum
NASDAQ Capital Market
FAQ
What is the OKYO Pharma share price?
As of Today at 16:29 UTC, shares in OKYO Pharma are trading at $1.25. This share price information is delayed by 15 minutes.
How has the OKYO Pharma share price performed this year?
Shares in OKYO Pharma last closed at $1.25 and the price had moved by +3.31% over the past 365 days. In terms of relative price strength the OKYO Pharma share price has underperformed the S&P500 Index by -17.8% over the past year.
What are the analyst and broker recommendations for OKYO Pharma?
There is no consensus recommendation for this security.
What is the OKYO Pharma dividend yield?
OKYO Pharma does not currently pay a dividend.
Does OKYO Pharma pay a dividend?
OKYO Pharma does not currently pay a dividend.
When does OKYO Pharma next pay dividends?
OKYO Pharma does not currently pay a dividend.
How do I buy OKYO Pharma shares?
To buy shares in OKYO Pharma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of OKYO Pharma?
As of the previous close price of $1.25, shares in OKYO Pharma had a market capitalisation of $74.13m.
Where are OKYO Pharma shares listed?
Here are the trading details for OKYO Pharma:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: OKYO
What kind of share is OKYO Pharma?
Based on an overall assessment of its quality, value and momentum OKYO Pharma is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a OKYO Pharma share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the OKYO Pharma share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like OKYO Pharma. Over the past six months, its share price has underperformed the S&P500 Index by -38.64%.
As of the last closing price of $1.25, shares in OKYO Pharma were trading -22.17% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the OKYO Pharma PE Ratio?
The OKYO Pharma PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.25.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of OKYO Pharma?
We do not have data on OKYO Pharma's directors